Does BlackRock own Regeneron?
BlackRock does not own Rentokil Initial PLC, but it is a major institutional investor in the company. As of March 2026, BlackRock increased its total holding in Rentokil to 12.33%, which includes both voting rights attached to shares and additional financial instruments. This makes BlackRock a significant stakeholder, though it remains a passive investor managing assets for its clients. Rentokil is a publicly traded company listed on the stock exchange, and it operates independently of any single parent entity. BlackRock’s involvement is purely financial, and it does not exert operational control over Rentokil's pest control or hygiene services. Its role is limited to standard shareholder engagement, proxy voting, and monitoring the company's financial performance to ensure it meets the investment mandates established for the various funds that hold these shares.
Related FAQs
Yes, you can buy stock in Revolution Medicines Inc. It is a publicly traded company listed on the NASDAQ stock exchange under the ticker symbol "RVMD.
Renesas Electronics Corporation demonstrates solid financial performance, operating as a global semiconductor powerhouse specializing in microcontrollers, analog devices, power management, and system-on-chip solutions for automotive, industrial, a...